According to the report, the global orthopedic devices industry generated $37.29 billion in 2018, and is projected to garner $47.79 billion by 2026, witnessing a CAGR of 3.1% from 2019 to 2026.

The spine implants market covered in this report is segmented by product into spinal fusion devices; non-fusion devices/motion preservation devices; vertebral compression fracture (VCF) treatment devices; spinal bone stimulators; spine biologics. It is also segmented by procedure into open surgery; minimally invasive surgery (MIS), by material into metallic; polymeric; ceramic and by end-use into hospitals; specialty orthopedic and spine centers; ambulatory surgical centers.

Increase in incidence of orthopedic injuries or diseases such as osteoporosis, traumatic fractures, osteoarthritis, and rheumatoid arthritis along with surge in aging population worldwide drive the global orthopedic devices market. However, high costs of different procedures that include orthopedic implants & treatments and stringent government policies restrain the market growth. Contrarily, huge potential in emerging countries offer lucrative opportunities in the coming years.

The spine implants market covered in this report is segmented by product into spinal fusion devices; non-fusion devices/motion preservation devices; vertebral compression fracture (VCF) treatment devices; spinal bone stimulators; spine biologics. It is also segmented by procedure into open surgery; minimally invasive surgery (MIS), by material into metallic; polymeric; ceramic and by end-use into hospitals; specialty orthopedic and spine centers; ambulatory surgical centers.

The innovation of implants in providing minimally invasive and motion-preserving stabilization is a major trend in the spine implants market. For example, RTI Surgical Holdings, a global surgical implant company, has launched the first and only posterior lumbar motion preservation solution, Coflex. Coflex is a differentiated, minimally-invasive, motion-preserving stabilization implant that is FDA PMA-approved for the treatment of moderate to severe lumbar spinal stenosis (LSS). It can be directly implanted following a surgical decompression, without fusing the bones. The device comes in different sizes to fit the patient’s anatomy, and this can be performed even in an outpatient setting.

Read More@ https://www.alliedmarketresearch.com/press-release/orthopaedic-devices-market.html